Human tumor-specific T lymphocytes: does function matter more than number?
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 17 (3) , 320-325
- https://doi.org/10.1016/j.coi.2005.03.002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909Journal of Clinical Investigation, 2005
- Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigenProceedings of the National Academy of Sciences, 2004
- Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytesProceedings of the National Academy of Sciences, 2004
- gp100209–2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T CellsClinical Cancer Research, 2004
- Individual Analysis of Mice Vaccinated against a Weakly Immunogenic Self Tumor-Specific Antigen Reveals a Correlation between CD8 T Cell Response and Antitumor EfficacyThe Journal of Immunology, 2003
- Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 PeptideThe Journal of Immunology, 2003
- Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox VirusThe Journal of Immunology, 2003
- Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+T-Cell ResponsesJournal of Clinical Oncology, 2003
- Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in HumansThe Journal of Experimental Medicine, 2002
- Intensity of the Vaccine-Elicited Immune Response Determines Tumor ClearanceThe Journal of Immunology, 2002